Aclaris Therapeutics
ACRS
ACRS
79 hedge funds and large institutions have $58.2M invested in Aclaris Therapeutics in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 81 → 79 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Holders
79
Holding in Top 10
1
Calls
$112K
Puts
$1K
Top Buyers
| 1 | +$4.72M | |
| 2 | +$3.95M | |
| 3 | +$1.54M | |
| 4 |
Morgan Stanley
New York
|
+$1.49M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$539K |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$2.6M | |
| 3 | -$1.2M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.03M |
| 5 |
BlackRock
New York
|
-$741K |